Yi-Hong Tsai 蔡逸宏

中文  │ English

蔡逸宏助理教授

Yi-Hong Tsai, Assistant Professor

Mentor of Class 3-3 in Pharmacy, 2025-2026.

Office & Lab: U932

Tel：08-7624002 ext. 2932/1123

E-mail: bear@tajen.edu.tw

coolOverall academic performance and ORCID information

As of November 1, 2025, Dr. Yi-Hong Tsai has published a total of 52 academic papers (SCI). According to Scopus Preview, the publications have accumulated 1,168 total citations across 1,136 SCI articles, with an h-index of 17 (Scopus Author ID: 54944623200). Based on Google Scholar, the h-index is 18, with 1,543 total citations (https://reurl.cc/9nMLZY). ORCID: https://orcid.org/0000-0003-4674-3363. In addition, 18 patents have been granted or are under review, and 8 transferred technologies have been successfully implemented in industry. Moreover, more than 30+ research projects have been involved in proposal writing, coordination, execution, and completion, including National Science and Technology Council (NSTC) research projects, government-funded initiatives, and industry–academia collaboration projects.

smileyCurrent positions

  • Assistant professor, Department of Pharmacy and Master Program, Collage of Pharmacy and Health Care, Tajen University, Taiwan.
  • Director, Office of Institutional Research and Sustainable Development, Office of Secretariat, Tajen University, Taiwan.

coolEducation

  • Ph.D. in PharmSci, Graduate Institute of Natural Products, Kaohsiung Medical University.

smileyEmployments and experiences

  • 2016-2023: Postdoctoral researcher, Graduate Institute of Natural Products, Kaohsiung Medical University, Taiwan.
  • 2019: Research abroad fellow, Faculty of Pharmacy, University of Szeged, Hungary.

wink Experiences

  • Pilot study of new botanic drugs, R&D on natural products and healthy foods.
  • Supercritical fluid extraction, Instrumental analysis, Spectroscopy, Pharmaceutical analysis and pharmacognosy.

yesAssociation attended

  • Overseas Member, the Pharmaceutical Society of Japan, 2025.
  • 2024 Academic Committee Members, The Natural Medicine Society of Taiwan (The Society of Chinese Natural Medicine, since 1988).
  • 2023 Academic Committee Members, The Natural Medicine Society of Taiwan (The Society of Chinese Natural Medicine, since 1988).
  • Life Member, The Natural Medicine Society of Taiwan (The Society of Chinese Natural Medicine, since 1988) .
  • Life Member, The Pharmaceutical Society of Taiwan.

heartAward

  • TJU – 2025 Campus Innovation and Creativity Practice Exemplary Award Competition – Excellence Award: Trends in Sustainable Product Design under the ESG Wave and International Green Supply Chain Chemical Management (Office of the Secretariat Team).
  • TJU – 2025 Campus Innovation and Creativity Practice Exemplary Award Competition – Excellence Award: Institutional Planning: Responsibility Mapping and Performance-Linked Mechanisms (Office of the Secretariat Team).
  • TJU – 2025 Campus Innovation and Creativity Practice Exemplary Award Competition – Merit Award: Advancing Together for a Brighter TJU (Office of the Secretariat Team).
  • TJU – 2025 Campus Innovation and Creativity Practice Exemplary Award Competition – Merit Award: Administrative Collaboration Platform: Digital Upgrade for Improved Efficiency (Office of the Secretariat Team).
  • TJU - 2024 Institutional Research Presentation and Workshop - First Place award: Enhancing the Funding and Implementation Performance of the MOE Subsidy Directions for the Development of Private Universities and Colleges of Technology (Office of the Secretariat Team).
  • TJU - 2024 Academic Year Teacher Incentive Program for Practical Teaching: Award for Teachers Developing and Applying Teaching Materials.
  • TJU - 2024 Academic Year Teacher Incentive Program for Promoting Practical Teaching.
  • TJU - 2024 Campus Innovation and Creativity Practice Exemplary Award Competition - Excellence Award: Application of AI and SDGs Sustainability Concepts in Lesson Plan Design and Techniques to Enhance Administrative Efficiency (Office of the Secretariat Team).
  • TJU - 2024 Campus Innovation and Creativity Practice Exemplary Award Competition - Excellence Award: Development of Unique Features and Resource Value-Added Activation in Higher Education Institutions (Office of the Secretariat Team).
  • TJU - 2024 Campus Innovation and Creativity Practice Exemplary Award Competition - Merit Award: Program for Enhancing Leadership Consensus and Cross-Unit Collaboration Efficiency (Office of the Secretariat Team).
  • TJU - "Recruitment and Retention of Outstanding Talent" Flexible Allowance Incentive, 114.
  • TJU - "Recruitment and Retention of Outstanding Talent" Flexible Allowance Incentive, 113.
  • TJU - "Recruitment and Retention of Outstanding Talent" Flexible Allowance Incentive, 112.
  • The Society of Chinese Natural Medicine (SCNM) -Outstanding Academic Award in Natural Products – Young Scholar Award, the 37th Symposium on Natural Products & the Ceremony in Honor of Late Academician Professor Kuo-Hsiung Lee - Nature is the Best Guide, 2022.
  • Kaohsiung Medical University -9th Campus Innovation and Entrepreneurship Competition - Entrepreneurship Category - Third Place, EPIC FUNGI, 2020.

wink Journal reviewer

  1. Review Editor for Ethnopharmacology, Frontiers in Pharmacology (Impact factor = 4.40. Ranked Q1, Top 18.2% in PHARMACOLOGY & PHARMACY - SCIE).
  2. Reviewer, Phytomedicine. (Impact factor = 6.70. Ranked Q1, Top 3.5% in INTEGRATIVE & COMPLEMENTARY MEDICINE - SCIE).

coolPublications

  1. Ya-Ting Chuang, Ching-Yu Yen, Jen-Yang Tang, Yi-Hong Tsai, Fang-Rong Chang, Tsu-Ming Chien, Hsueh-Wei Chang, 2025. “Anti-acrolein from natural products by regulating miRNAs and targets.” J. Hazard. Mater., 499:140245. (Impact factor = 11.3. Ranked Q1, Top 5.05%% in ENVIRONMENTAL SCIENCES - SCIE).
  2. Ya-Ting Chuang, Ching-Yu Yen, Wangta Liu, Tsu-Ming Chien, Fang-Rong Chang, Yi-Hong Tsai, Jen-Yang Tang, Hsueh-Wei Chang, 2025. “The protection of bisphenol A-modulated miRNAs and targets by natural products.” Environ. Int., 196, 109299. (Impact factor = 10.3. Ranked Q1, Top 5.7% in ENVIRONMENTAL SCIENCES - SCIE).
  3. Wan-Hsuan Chang, Yu-Fan Chuang, Po-Chien Li, Hung-Te Hsu, Wei-Yu Fang, Szu-Yin Yu, Yi-Hong Tsai, Chih-Lung Lin, Fang-Rong Chang, Yi-Ching Lo, 2024. “Gan-Mai-Da-Zao-Tang attenuates age-induced skeletal muscle wasting and improves mitochondrial function in mice.” J. Tradit. Med. Complement., accepted, in press. (Impact factor = 3.3. Ranked Q1, Top 19.8% in INTEGRATIVE & COMPLEMENTARY MEDICINE - SCIE).
  4. Ya-Ting Chuang, Ching-Yu Yen, Jen-Yang Tang, Fang-Rong Chang, Yi-Hong Tsai, Kuo-Chuan Wu, Tsu-Ming Chien, Hsueh-Wei Chang, 2024. “The modulation of immune cell death in connection to microRNAs and natural products.” Front. Immunol. 15:1425602. (Impact factor = 5.7. Ranked Q1, Top 20.2% in IMMUNOLOGY - SCIE).
  5. Ya-Ting Chuang, Ching-Yu Yen, Tsu-Ming Chien, Fang-Rong Chang, Kuo-Chuan Wu, Yi-Hong Tsai, Jun-Ping Shiau, Hsueh-Wei Chang, 2024. “Natural products modulate phthalate-associated miRNAs and targets.” Ecotoxicol. Environ. Saf., 284:117015. (Impact factor = 6.2. Ranked Q1, Top 8.0% in TOXICOLOGY - SCIE).
  6. Ya-Ting Chuang, Ching-Yu Yen, Jen-Yang Tang, Kuo-Chuan Wu, Fang-Rong Chang, Yi-Hong Tsai, Tsu-Ming Chien, Hsueh-Wei Chang, 2024. “Marine anticancer drugs in modulating miRNAs and antioxidant signaling.” Chem. Biol. Interact., 25(399):111142. (Impact factor = 4.7. Ranked Q1, Top 15.4% in PHARMACOLOGY & PHARMACY - SCIE).
  7. Ya-Ting Chuang, Ching-Yu Yen, Tsu-Ming Chien, Fang-Rong Chang, Yi-Hong Tsai, Kuo-Chuan Wu, Jen-Yang Tang, Hsueh-Wei Chang, 2024. “Ferroptosis-Regulated Natural Products and miRNAs and Their Potential Targeting to Ferroptosis and Exosome Biogenesis.” Int. J. Mol. Sci., 25(11): 6083. (Impact factor = 4.9. Ranked Q1, Top 20.9% in BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE).
  8. Hao-Chun Hu, Szu-Yin Yu, Yi-Hong Tsai, Pei-Wen Hsieh, Hui-Chun Wang, Yan-Ning Chen, Ya-Ting Chuang, Min-Yu Lee, Hsueh-Wei Chang, Hao-Chun Hu, Yang-Chang Wu, Fang-Rong Chang, István Szatmári, Ferenc Fülöp, 2024. “Synthesis of bioactive evodiamine and rutaecarpine analogues under a ball milling condition.” Org. Biomol. Chem., 22, 2620-2629. (Impact factor = 2.9. Ranked Q1, Top 21.6% in CHEMISTRY, ORGANIC - SCIE).
  9. Yi-Hong Tsai1, Yen Chi Loo1, Hsieh Chen, Hui-Ping Hsieh, Yen-Chang Chen, Hsueh-Er Chen, Zhi-Hu Lin, Tse-Hung Huang, I-Min Liu, Chia-Ching Liaw, Fang-Rong Chang, 2024. “Quality and production enhancement of fish mint, Houttuynia cordata Thunb., cultivated in a hydroponic planting system with designed plant growth-promoting additives.” Heliyon, 10(7):e28755. (Impact factor = 3.4. Ranked Q1, Top 20.5% in MULTIDISCIPLINARY SCIENCES - SCIE). First author.
  10. Ya-Ting Chuang, Ching-Yu Yen, Jen-Yang Tang, Fang-Rong Chang, Yi-Hong Tsai, Kuo-Chuan Wu, Tsu-Ming Chien, Hsueh-Wei Chang, 2024. “Protein phosphatase 2A modulation and connection with miRNAs and natural products.” Environ. Toxicol, 39(6):3612-3627. (Impact factor = 4.4. Ranked Q1 in TOXICOLOGY - SCIE).
  11. Ya-Ting Chuang, Ching-Yu Yen, Jun-Ping Shiau, Fang-Rong Chang, Chang-Yih Duh, Ping-Jyun Sung, Kuan-Liang Chen, Yi-Hong Tsai, Jen-Yang Tang, Jiiang-Huei Jeng, Jyh-Horng Sheu, Hsueh-Wei Chang, 2024. “Demethoxymurrapanine, an indole-naphthoquinone alkaloid, inhibits the proliferation of oral cancer cells without major side effects on normal cells.” Environ. Toxicol., 39(3), 1221–1234. (Impact factor = 4.4. Ranked Q1, Top 18% in TOXICOLOGY - SCIE).
  12. Jen-Yang Tang, Ya-Ting Chuang, Jun-Ping Shiau, Ching-Yu Yen, Fang-Rong Chang, Yi-Hong Tsai, Ammad Ahmad Farooqi, Hsueh-Wei Chang, 2023. “Connection between Radiation-Regulating Functions of Natural Products and miRNAs Targeting Radiomodulation and Exosome Biogenesis.” Int. J. Mol. Sci., 24(15):12449. (Impact factor = 6.208. Ranked Q1, Top 23% in BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE).
  13. Ya-Ting Chuang, Jun-Ping Shiau, Jen-Yang Tang, Ammad Ahmad Farooqi, Fang-Rong Chang, Yi-Hong Tsai, Ching-Yu Yen, Hsueh-Wei Chang*, 2023. “Connection of Cancer Exosomal LncRNAs, Sponging miRNAs, and Exosomal Processing and Their Potential Modulation by Natural Products.” Cancers, 15(8), 2215. (Impact factor = 6.675. Ranked Q1, Top 24.29% in ONCOLOGY - SCIE).
  14. Yen Chi Loo, Hao-Chun Hu, Szu-YinYu, Yi-Hong Tsai, Michal Korinek, Yang-ChangWu*, Fang-Rong Chang*, Ying-JungChen*, 2023. “Development on potential skin anti-aging agents of Cosmos caudatus Kunth via inhibition of collagenase, MMP-1 and MMP-3 activities.” Phytomedicine, 110:154643. (Impact factor = 6.655. Ranked Q1, No.1 in INTEGRATIVE & COMPLEMENTARY MEDICINE - SCIE).
  15. Wei-Yu Fang, Chih-Lung Lin, Wan-Hsuan Chang, Chih-Hsiang Chang, Yun-Cian Huang, Yi-Hong Tsai, Fang-Rong Chang, Yi-Ching Lo*, 2022. “Protective effects of a chalcone-based derivative AN07 on inflammation-associated myotube atrophy induced by lipopolysaccharide.” Int. J. Mol. Sci., accepted, Int. J. Mol. Sci., 23(21):12929. (Impact factor = 6.208. Ranked Q1, Top 23% in BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE).
  16. Wei-Yu Fang, Wan-Hsuan Chang, Yi-Hong Tsai, Hung-Te Hsu, Feng-Rong Chang, Chih-Lung Lin, Yi-Ching Lo*, 2022. “Guilu Erxian Jiao enhances protein synthesis, glucose homeostasis, mitochondrial biogenesis and slow-twitch fibers in the skeletal muscle.” J. Food Drug Anal., 31(1), Article 8. (Impact factor = 6.157. Ranked Q1, Top 16% in PHARMACOLOGY & PHARMACY - SCIE).
  17. Hao-Chun Hu, Szu-Yin Yu, Xiao-Shan Hung, Chun-Han Su, Yu-Liang Yang, Chien-Kei Wei, Yuan-Bin Cheng, Yang-Chang Wu, Chia-Hung Yen, Tsong-Long Hwang, Shu-Li Chen, István Szatmári, Attila Hunyadi, Yi-Hong Tsai*, Fang-Rong Chang*, 2022. “Composition decipherment of F. pumila var. awkeotsang and its potential on COVID-19 symptom amelioration and in silico prediction of SARS-CoV-2 interference.” J. Food Drug Anal., 30(3), Article 9. (Impact factor = 6.157. Ranked Q1, Top 16% in PHARMACOLOGY & PHARMACY - SCIE). Corresponding author.
  18. Michal Korinek, Heba Handoussa, Olha Mykhailenko, Meng-Hua Chen, Zan-Wei Chiou, You-Ying Chen, Yi-Hong Tsai, Bing-Hung Chen, Mohamed El-Shazly, Tsong-Long Hwang*, 2021. “Antimicrobial and anti-inflammatory effects of volatile oils widely used in Mediterranean diet.” Free Radic. Biol. Med., 165(1), 38. (Impact factor = 8.101. Ranked Q1, Top 9% in ENDOCRINOLOGY & METABOLISM).
  19. Wei-Kuang Lai, Yang-Chang Wu, Tai-Sheng Yeh, Chun-Ren Hsieh, Yi-Hong Tsai, Chien-Kei Wei, Chi-Ying Li, Ying-Chen Lu*, Fang-Rong Chang*, 2021. “The protoplast two-way fusions and fusant characteristics of Antrodia cinnamomea and Cordyceps militaris.” Food Sci. Hum. Wellness, 11(5), 1240-1251. (Impact factor = 8.022. Ranked Q1, Top 10% in NUTRITION & DIETETICS - SCIE).
  20. Abdel Nasser B Singab, Nada M Mostafa, Yasmin A Elkhawas, Eman Al-Sayed, Mokhtar M Bishr, Ahmed M Elissawy, Mohamed S Elnaggar, Iten M Fawzy, Osama M Salama, Yi-Hong Tsai, Fang-Rong Chang*, 2021. “Cyclodepsipeptides: isolation from endophytic fungi of Sarcophyton ehrenbergi and verification of their larvicidal activity via in-vitro and in-silico studies.” Mar. Drugs., 20(5), 331. (Impact factor = 6.085, ranked Q1, Top 16% in CHEMISTRY, MEDICINAL - SCIE).
  21. Yi-Hong Tsai, Fang-Rong Chang*, YangChang Wu*, 2022. “In memory of professor Kuo-Hsiung Lee (K. H. Lee).” J. Tradit. Complement. Med. 12(2), 217-218. (Impact factor = 4.221. Ranked Q2, top 27% in INTEGRATIVE & COMPLEMENTARY MEDICINE)). First author.
  22. Chi-Jung Tai, Mohamed El-Shazly, Yi-Hsin Yang, Yi-Hong Tsai, Dezső Csupor, Judit Hohmann, Yang-Chang Wu, Tzyy-Guey Tseng, Fang-Rong Chang*, Hui-Chun Wang*, 2022. “The effectiveness of Fuzi in combination with routine heart failure treatment on chronic heart failure patients” J. Ethnopharmacol., 289: 115040. (Impact factor = 5.195. Ranked Q1, Top 12.98% in INTEGRATIVE & COMPLEMENTARY MEDICINE - SCIE).
  23. Chiao-Chih Huang, Tzu-Ching Lin, Chiung-Hui Liu, Hao-Chun Hu, Szu-Yin Yu, Shu-Jing Wu, Ming-Hong Yen, Yi-Hong Tsai*, Fang-Rong Chang*, 2021. “Lipid metabolism and its mechanism triggered by supercritical CO2 extract of adlay (Coix lacryma-jobi var. ma-yuen (Rom. Caill.) Stapf) bran in high fat diet-induced hyperlipidemic hamsters.” Front. Pharmacol., 12:785944. (Impact factor = 5.988. Ranked Q1, Top 18% in PHARMACOLOGY & PHARMACY - SCIE). Corresponding author.
  24. Michal Korinek, Heba Handoussa, Yi-Hong Tsai, You-Ying Chen, Meng-Hua Chen, Zan-Wei Chiou, Yu Fang, Fang-Rong Chang, Chia-Hung Yen, Chung-Fan Hsieh, Bing-Hung Chen, Mohamed El-Shazly, Tsong-Long Hwang, 2021. “Anti-inflammatory and antimicrobial volatile oils: Fennel and cumin inhibit neutrophilic inflammation via regulating Calcium and MAPKs.” Front. Pharmacol., 12:674095. (Impact factor = 5.988. Ranked Q1, Top 18 in PHARMACOLOGY & PHARMACY - SCIE).
  25. Kartiko Arif Purnomo, Michal Korinek, Yi-Hong Tsai, Hao-Chun Hu, Yi-Hsuan Wang, Anders Backlund, Tsong-Long Hwang, Bing-Hung Chen, Shih-Wei Wang, Chin-Chung Wu, Fang-Rong Chang*, 2021. “Decoding multiple biofunctions of maca on its anti-allergic, anti-inflammatory, anti-thrombotic, and pro-angiogenic activities.” J. Agri. Food Chem., 69(40):11856-11866. (Impact factor = 5.895. Ranked Q1, Top 10% in AGRICULTURE, MULTIDISCIPLINARY - SCIE).
  26. Bernard S. Canusa, Ivan L. Lawag, Oliver B. Villaflores, Vitthal D. Wagh, Michal Korinek, Yi-Hong Tsai, Fang-Rong Chang, Ma. Alicia M. Aguinaldo*, 2021. “α-Glucosidase inhibitors from the bark extract of ethno-antidiabetic Ceriops tagal (Perr.) C.B. Rob” Philipp. J. Sci., 151 (S1): 25-60.
  27. Yi-Hong Tsai1, Hao-Chun Hu1, Yu-Che Chuang, Kuei-Hung Lai, Yu-Ming Hsu, Tsong-Long Hwang, Chih-Chan Lin, Ferenc Fülöp, Yang-Chang Wu, Szu-Yin Yu, Yu-Ting Kuo*, Fang-Rong Chang*, 2021. “Estrogenic and anti-neutrophilic inflammatory phenanthrenes from Juncus effusus L.” Nat. Prod. Res., 2021 Sep 9;1-11. (Impact factor = 2.861. Ranked Q2 in CHEMISTRY, APPLIED - SCIE). First author.
  28. Ching-Chia Chang, Chi-Ying Li, Yi-Hong Tsai, Mohamed El-Shazly, Chien-Kei Wei, Zih-Jie Yang, Shu-Li Chen, Chin-Chung Wu, Yang-Chang Wu, Fang-Rong Chang *, 2021. “Bioactive polyketides from the pathogenic fungus of Epicoccum sorghinum.” Planta, 253(6):116. (Impact factor = 4.540. Ranked Q1, Top 17% in PLANT SCIENCES - SCIE).
  29. Chi-Jung Tai, Mohamed El-Shazly, Yi-Hong Tsai, Dezső Csupor, Judit Hohmann, Yang-Chang Wu, Tzyy-Guey Tseng, Fang-Rong Chang*, Hui-Chun Wang*, 2021. “Uncovering modern clinical applications of Fuzi and Fuzi-based formulas: A nationwide descriptive study with market basket analysis.” Front. Pharmacol., 12:674095. (Impact factor = 5.988. Ranked Q1, Top 18 in PHARMACOLOGY & PHARMACY - SCIE).
  30. Tzu-Jung Yu, Yuan-Bin Cheng, Li-Ching Lin, Yi-Hong Tsai, Bo-Yi Yao, Jen-Yang Tang, Fang-Rong Chang, Chia-Hung Yen, Fu Ou-Yang, Hsueh-Wei Chang*, 2021. “Physalis peruviana-derived physapruin A (PHA) inhibits breast cancer cell proliferation and induces oxidative-stress-mediated apoptosis and DNA damage.” Antioxidants, 10(3):393. (Impact factor = 7.675. Ranked Q1, Top 6% in CHEMISTRY, MEDICINAL - SCIE).
  31. Wei-Kuang Lai, Ying-Chen Lu, Chun-Ren Hsieh, Chien-Kei Wei, Yi-Hong Tsai, Fang-Rong Chang*, You Chan*, 2021. “Developing lactic acid bacteria as an oral healthy food.” Life-Basel, 11(4): 268. (Impact factor = 3.251. Ranked Q2 in BIOLOGY - SCIE).
  32. Hao-Chun Hu, Chi-Ying Li, Yi-Hong Tsai, Dai-Yun Yang, Yang-Chang Wu, Tsong-Long Hwang, Shu-Li Chen, Ferenc Fülöp, Attila Hunyadi, Chia-Hung Yen, Yuan-Bin Cheng, Fang-Rong Chang*, 2020. “Secondary metabolites and bioactivities of Aspergillus ochraceopetaliformis isolated from Anthurium brownie.” ACS Omega, 5(33):20991-20999. (Impact factor = 4.132. Ranked Q2 in CHEMISTRY, MULTIDISCIPLINARY - SCIE).
  33. Chi-Ying Li, Ching-Chia Chang, Yi-Hong Tsai, Mohamed El-Shazly, Chin-Chung Wu, Shih-Wei Wang, Tsong-Long Hwang, Chien-Kei Wei, Judit Hohmann, Zih-Jie Yang, Yuan-Bin Cheng, Yang-Chang Wu, Fang-Rong Chang*, 2020. “Anti-inflammatory, antiplatelet aggregation, and antiangiogenesis polyketides from Epicoccum sorghinum: Toward an understating of its biological activities and potential applications.” ACS Omega, 5(19), 11092–11099. (Impact factor = 4.132. Ranked Q2 in CHEMISTRY, MULTIDISCIPLINARY - SCIE).
  34. Chih-Wen Chen, Chih-Fong Tsai, Yi-Hong Tsai, Yang-Chang Wu*, Fang-Rong Chang*, 2020. “Association rule mining for the ordered placement of traditional Chinese medicine containers: An experimental study.” Medicine, 99(18): e20090. (Impact factor = 1.817. Ranked Q3 in MEDICINE, GENERAL & INTERNAL – SCIE).
  35. Chih‐Wen Chen, Yi‐Hong Tsai, Fang‐Rong Chang, Wei‐Chao, Lin*, 2020. “Ensemble feature selection in medical datasets: Combining filter, wrapper, and embedded feature selection results.” Expert Syst., e12553. (Impact factor = 2.812. Ranked Q2, Top 34% in COMPUTER SCIENCE, THEORY & METHODS - SCIE).
  36. Yun-Chien Lai, Chi-Jung Tai1, Mohamed El-Shazly, Yu-Che Chuang, Shu-Tuan Chiang, Yi-Hong Tsai, Dezső Csupor, Judith Hohmann, Yang-Chang Wu*, Fang-Rong Chang*, 2019. “Quantification and simplified detoxification investigation on Fuzi, root of Aconitum carmichaelii.” Nat. Prod. Commun., 14(10), 1-8.
  37. Yu-Ting Tseng, Yi-Hong Tsai¸ Ferenc Fülöp, Fang‐Rong Chang, and Yi-Ching Lo*, 2019. “2-Iodo-4’-methoxychalcone attenuates methylglyoxal-induced neurotoxicity by activation of GLP-1 receptor and enhancement of neurotrophic signal, antioxidant defense and glyoxalase pathway.” Molecules, 24(12), 2249.
  38. Hung Su, Kuan-Ting Liu, Bai-Hsiun Chen, Yen-Ping Lin, Yu-Min Jiang, Yi-Hong Tsai¸ Fang-Rong Chang, Jentaie Shiea*, Chi-Wei Lee*, 2019. “Rapid identification of herbal toxins using electrospray laser desorption ionization mass spectrometry for emergency care.” J. Food Drug Anal., 27, 2, 415−427.
  39. Chi-Ying Li, I-Wen Lo, Yen-Ping Hsueh, Yu-Ming Chung, Shih-Wei Wang, Michal Korinek, Yi-Hong Tsai¸ Yuan-Bin Cheng, Tsong-Long Hwang, Clay C. C. Wang, Fang-Rong Chang, Yang-Chang Wu, 2019. “Epigenetic manipulation induces the production of coumarin-type secondary metabolite from Arthrobotrys foliicola.” Isr. J. Chem., 59(5), 432-438.
  40. Chi-Ting Hsieh, Fang-Rong Chang, Yi-Hong Tsai, Yang-Chang Wu and Tusty-Jiuan Hsieh*, 2018. “2-Bromo-4’-methoxychalcone and 2-iodo-4’-methoxychalcone prevent progression of hyperglycemia and obesity via 5’-adenosine-monophosphate-activated protein kinase in diet-induced obese mice.” Int. J. Mol. Sci., 19(9), 2763.
  41. Yi-Hong Tsai1, Chien-Kei Wei1, Michal Korinek, Pei-Hsuan Hung, Mohamed El-Shazly, Yuan-Bin Cheng, Yang-Chang Wu, Tusty-Jiuan Hsieh*, and Fang-Rong Chang*, 2017. “6-Paradol and 6-shogaol, the pungent compounds of ginger, promote glucose utilization in adipocytes and myotubes, and 6-paradol reduces blood glucose in high-fat diet mice.” Int. J. Mol. Sci., 18(1), 168. First author.
  42. Michal Korinek, Yi-Hong Tsai, Mohamed El-Shazly, Kuei-Hung Lai, Anders Backlund, Shou-Fang Wu, Wan-Chun Lai, Tung-Ying Wu, Shu-Li Chen, Yang-Chang Wu, Yuan-Bin Cheng, Tsong-Long Hwang*, Bing-Hung Chen*, and Fang-Rong Chang*, 2017. “Anti-allergic hydroxy fatty acids from Typhonium blumei explored through ChemGPS-NP.” Front. Pharmacol., 8, 356.
  43. Santhaseelan Henciya, Prabha Seturaman, Arthur Rathinam James, Yi-Hong Tsai, Rahul Nikam, Yang-Chang Wu, Hans-Uwe Dahms, Fang-Rong Chang*, 2017. “Biopharmaceutical potentials of Prosopis spp. (Mimosaceae, Leguminosa).” J. Food Drug Anal., 25(1), 187−196.
  44. Santhaseelan Henciya, Prabha Seturaman, Arthur Rathinam James, Yi-Hong Tsai, Rahul Nikam, Yang-Chang Wu, Hans-Uwe Dahms, Fang-Rong Chang*, 2017. “Corrigendum to “Biopharmaceutical potentials of Prosopis spp. (Mimosaceae, Leguminosa)” (Journal of Food and Drug Analysis (2017) 25(1) (S1021949816301697) (10.1016/j.jfda.2016.11.001))” J. Food Drug Anal., 25(3), 748−749.
  45. Yi-Hong Tsai1, Yuan-Bin Cheng1, I-Wen Lo, Chen-Chang Haung, Yu-Chi Tsai, Ludger Beerhues, Mohamed El-Shazly, Ming-Feng Hou, Shyng-Shiou Yuan, Chin-Chung Wu, Fang-Rong Chang*, and Yang-Chang Wu*, 2015. “Pandalisines A and B, novel indolizidine alkaloids from the leaves of Pandanus utilis.” Bioorg. Med. Chem. Lett., 25, 4333–4336. First author.
  46. Tung-Ying Wu, Ying-Chi Du, Yu-Ming Hsu, Chi-Yu Lu, Abdel Nasser B. Singab, Mohamed El-Shazly, Tsong-Long Hwang, Wan-Yu Lin, Kuei-Hung Lai, Mei-Chin Lu, Yi-Hong Tsai, Ming-Feng Hou, Tsai-Hui Du*, and Fang-Rong Chang*, 2013. “New approach to the characterization and quantification of Antrodia cinnamomea benzenoid components utilizing HPLC-PDA, qNMR and HPLC-tandem MS: Comparing the wild fruiting bodies and its artificial cultivated commercial products.” Food Res. Int., 51, 23−31.
  47. Chia-Lin Lee, Tsong-Long Hwang, Wan-Jung He, Yi-Hong Tsai, Chiao-Ting Yen, Hsin-Fu Yen, Chao-Jung Chen, Wei-Yi Chang, Yang-Chang Wu, 2013. “Anti-neutrophilic inflammatory steroidal glycosides from Solanum torvum.” Phytochemistry, 95, 315-321.
  48. Yi-Hong Tsai1, Tusty-Jiuan Hsieh, Min-Chun Liao, Ying-Chi Du, Pei-Jung Lien, Chuan-Chia Sun, Fang-Rong Chang*, and Yang-Chang Wu*, 2012. “Anti-diabetic properties of non-polar Toona sinensis Roem. extract prepared by supercritical-CO2 fluid.” Food Chem. Toxicol., 50, 779−789. First author.
  49. Chi-Ting Hsieh, Tusty-Jiuan Hsieh, Mohamed El-Shazly, Da-Wei Chuang, Yi-Hong Tsai, Chiao-Ting Yen, Shou-Fang Wu, Yang-Chang Wu*, and Fang-Rong Chang*, 2012. “Synthesis of Chalcone Derivatives as Potential Anti-diabetic Agents.” Bioorg. Med. Chem. Lett., 22, 3912−3915.
  50. Balaji D. Barve, Yang-Chang Wu, Mohamed El-Shazly, Da-Wei Chuang, Yu-Ming Chung, Yi-Hong Tsai, Shou-Fang Wu, Michal Korinek, Ying-Chi Du, Chi-Ting Hsieh, Jeh-Jeng Wang*, and Fang-Rong Chang*, 2012. “Synthesis of carbamates by direct C–H bond activation of formamides.” Eur. J. Org. Chem., 34, 6760−6766.
  51. Tusty-Jiuan Hsieh, Pei-Chen Hsieh, Yi-Hong Tsai, Chia-Fang Wu, Chia-Chu Liu, Ming-Yen Lin, Ming-Tsang Wu*, 2012. “Melamine induces human renal proximal tubular cell injury via transforming growth factor-β and oxidative stress.” Toxicol. Sci., 130(1), 17-32.
  52. I-Min Liu, Wen-Jen Yu, Shorong-Shii Liou, Thing-Fong Tzeng, Yi-Hong Tsai, Juei-Tang Cheng*, 2007. “Role of alcohol in the induction of hepatic injury by chronic consumption of medicated wine.” J. Food Drug Anal., 15, 4, Article 4.

enlightenedGranted and filing Patents

  1. Invention, Title: Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic disease, the preparation method and the use thereof, Country: USA, Patent No.: US10668122B2 
  2. Invention, Title: Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method and the use thereof, Country: TW, Patent No.: I492755 
  3. Invention, Title: Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method and the use thereof, Country: CN, Patent No.: CN102821771B 
  4. Invention, Title: Composition for treating diabetes and metabolic diseases and a preparation method thereof, Country: USA, Patent No.: US9085520B2 
  5. Invention, Title: Composition for treating diabetes and metabolic diseases and a preparation method thereof, Country: TW, Patent No.: I417088 
  6. Invention, Title: Multiple beneficial functions of maca as anti-allergic, anti-neutrophilic inflammatory, anti-thrombotic, and pro-angiogenic agents and use thereof, Country: USA, Patent No.: US11771729B2
  7. Invention, Title: Multiple beneficial functions of maca as anti-allergic, anti-neutrophilic inflammatory, anti-thrombotic, and pro-angiogenic agents and use thereof, Country: JP, Patent No.: JP7446003B2 
  8. Invention, Title: Multiple beneficial functions of maca as anti-allergic, anti-neutrophilic inflammatory, anti-thrombotic, and pro-angiogenic agents and use thereof, Country: CN, Patent No.: CN115477604B 
  9. Invention, Title: Multiple beneficial functions of maca as anti-allergic, anti-neutrophilic inflammatory, anti-thrombotic, and pro-angiogenic agents and use thereof, Country: TW, Patent No.: I874771
  10. Invention, Title: Hibiscus sabdariffa seed extract for anti-oxidation, anti-inflammation, anti-UVB damage, anti-allergy, whitening, moisturizing and anti-wrinkle formation, Country: TW, Publication No.: TW202337482A
  11. Invention, Title: Hibiscus sabdariffa seed extract for anti-oxidation, anti-inflammation, anti-UVB damage, anti-allergy, whitening, moisturizing and anti-wrinkle formation, Country: CN, Publication No.: CN116019744A 
  12. Invention, Title: Hibiscus sabdariffa seed extract for anti-oxidation, anti-inflammation, anti-UVB damage, anti-allergy, whitening, moisturizing and anti-wrinkle formation, Country: USA, Publication No.: US20230131367A1
  13. Invention, Title: Use of Caulerpa lentillifera extract for making a composition promoting anti-inflammation, anti-oxidation and anti-cancer of skin, Country: TW, Patent No.: I790760 
  14. Invention, Title: Use of Caulerpa lentillifera composition for promoting anti-inflammation, anti-oxidation, slowing down collagen degradation and anti-cancer of skin, Country: TW, Patent No.: I837515 
  15. Invention, Title: Houttuynia cordata hydroponic culture medium, system and extract of Houttuynia cordata produced by the same and its preparation, Country: TW, Patent No.: I838761
  16. Invention, Title: Houttuynia cordata hydroponic culture medium, system and extract of Houttuynia cordata produced by the same and its preparation, Country: CN, Publication No.: CN117185866A
  17. Invention, Title: Houttuynia cordata hydroponic culture medium and system, Country: USA, US Patent App. 18/956,346
  18. Utility Model, Title: Device for extracting branches and leaves of Ficus pumila var. awkeotsang, Country: TW, Patent No.: M643653 
 

angelTechnology transfers

  1. Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method, and the use thereof. Taiwan patent: I492755. Patent Holder: Kaohsiung medical university. Current Assignee: We-Yu Applied Bio-tech Co., Ltd. Royalty: 300,000 NTD.
  2. Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method, and the use thereof. China patent: I492755. Patent Holder: Kaohsiung medical university. Current Assignee: We-Yu Applied Bio-tech Co., Ltd. Royalty: 1,200,000 NTD.
  3. Composition for treating diabetes and metabolic diseases and a preparation method thereof. Taiwan patent: I417088; USA patent: US9085520B2. Patent Holder: Kaohsiung medical university. Current Assignee: Oneness Biotech Co., Ltd. Royalty: 30,000,000 NTD (in millstones).
  4. Multiple beneficial functions of maca as anti-allergic, anti-neutrophilic inflammatory, anti-thrombotic, and pro-angiogenic agents and use thereof. US patant: US 11,771,729 B2. Filing patants: Taiwan, Japan, and China patents. Patent Holder: Kaohsiung medical university. Current Assignee: Root & Stem Future biotechnology Co., Ltd. Royalty: 2,000,000 NTD.
  5. Zink your heart drink. Patent Holder: Kaohsiung medical university. Current Assignee: Joben Bio-Medical Co., Ltd. Royalty: 1,000,000 NTD.
  6. Vitality up Antrodia cinnamomea Drink. Patent Holder: Kaohsiung medical university. Current Assignee: Joben Bio-Medical Co., Ltd. Royalty: 1,000,000 NTD.
  7. Energy and Beauty Soy Protein Isolate. Vitality up Antrodia cinnamomea Drink. Patent Holder: Kaohsiung medical university. Current Assignee: Joben Bio-Medical Co., Ltd. Royalty: 1,000,000 NTD.
  8. An enzymatic formulation with inhibitory activity against oil droplet formation. Patent Holder: Kaohsiung medical university. Current Assignee: Joben Bio-Medical Co., Ltd. Royalty: 1,000,000 NTD.

coolProject participation and conducts

  1. Government funded projects (PI: Prof. Fang-Rong Chang):
  1. National Science and Technology Council, NSTC (Ministry of Science and Technology, MOST) projects - Integrated project:
  • R&D of precisely agricultural products in preventing cardiovascular risks and metabolic syndrome (111-2321-B-037 -004)，2022/07/01 ~ 2025/06/30。
  1. NSTC (MOST) projects - General project:
  • (Principal investigator, PI) NSTC-113-2320-B-127 -001，2024/08/01 ~ 2025/07/31.
  • Using chemical and physical stimulations in genetic modulation for the development of fungal secondary metabolites (111-2320-B-037 -020 -MY3), 2022/08/01 ~ 2025/07/31.
  • Natural products research and development under genetic and signaling expression modulation in fungi (MOST 108-2320-B-037-022-MY3) + Structure-Activity Relationship Investigation on Natural Products Produced by Epigenetically Manipulated Fungi – Innovational R&D of Medicinal Natural Products (MOST International Cooperation Add-on Project Application Form, Magic), 2019/08/01 ~ 2022/07/31.
  • Epigenetic manipulation as a pathway to develop functional metabolites from fungi II (MOST 105-2628-B-037-001-MY3) + Semi- to total synthetic strategies for scaling up the functional metabolites from epigenetically manipulated fungus. (MOST International Cooperation Add-on Project Application Form, Magic),2016/08/01~2019/10/31.
  • Research & Development on Anti-allergic Materials of Aquilaria malaccensis (MOST 106-2320-B-037-008-MY2), 2017/08/01~2019/07/31.
  • Epigenetic manipulation as a pathway to develop functional metabolites from fungi (MOST 102-2628-B-037 -003-MY3), 2013/08/01 ~ 2016/07/31.
  1. NSTC (MOST) projects - International cooperative projects (PI: Prof. Fang-Rong Chang):
  • Chemical approaches in the quest for bioactive compounds IV. (2/2) - HAS-MOST Project-based Personnel Exchange Program, PPP between Ministry of Science and Technology, Taiwan and Hungarian Academy of Sciences, Hungary (MOST 111-2927-I-037-501), 2022/01/01 ~ 2022/12/31.
  • Chemical approaches in the quest for bioactive compounds IV. (1/2) - HAS-MOST Project-based Personnel Exchange Program, PPP between Ministry of Science and Technology, Taiwan and Hungarian Academy of Sciences, Hungary (MOST 109-2927-I-037-502), 2020/11/01 ~ 2021/10/30.
  • Chemical approaches in the quest for bioactive compounds III. (2/2) - HAS-MOST Project-based Personnel Exchange Program, PPP between Ministry of Science and Technology, Taiwan and Hungarian Academy of Sciences, Hungary (MOST 107-2911-I-037-502), 2018/05/01~2019/10/31.
  • Chemical approaches in the quest for bioactive compounds III. (1/2) - HAS-MOST Project-based Personnel Exchange Program, PPP between Ministry of Science and Technology, Taiwan and Hungarian Academy of Sciences, Hungary (MOST 106-2911-I-037-504), 2017/01/01~2017/12/31.
  • Chemical approaches in the quest for bioactive compounds II. (2/2) - HAS-MOST Project-based Personnel Exchange Program, PPP between Ministry of Science and Technology, Taiwan and Hungarian Academy of Sciences, Hungary, (MOST 105-2911-I-037-501), 2016/01/01~2016/12/31.
  1. NSTC (MOST) projects - National R&D projects (PI: Prof. Yang-Chang Wu and Fang-Rong Chang):
  • Drug Development of Novel Chalcone Derivatives against Diabetes and Metabolic syndrome (II), MOST 99-2323-B-037-002, 2010/10/01~2011/07/31.
  • WYC-01 and WYC-02 New Drug Preclinical Research and Development, MOST 99-2323-B-039 -002, 2010/08/01 ~ 2011/07/31.
  • Drug Development of Novel Chalcone Derivatives against Diabetes and Metabolic syndrome, MOST 98-2323-B-037-004, 2009/10/01 ~2010/10/31.
  1. Department of Chinese Medicine and Pharmacy, MOHW：
  • Project Co-PI: Revision and Consultation on Quality Standards and Technical Specifications of the Taiwan Herbal Pharmacopeia. MOHW114-CMAP-M-113-000003, 2025/02/20~2025/12/31.
  • Project Co-PI: Compilation and consultation of botanical origin specifications of Chinese herbal medicine, MOHW113-CAMP-M-123-000401-B, 2024/02/27~2024/12/31.
  1. Agriculture and Food Agency, Council of Agriculture, Executive Yuan, Taiwan (PI: Prof. Fang-Rong Chang and Chia-Chung Chen):
  • Establishment of Philippine Tropical Facility Base and Cooperative Development Program for Health Crop Products, 2017. 106農科-21.1.3-糧-Z2, 2017/01/01 ~ 2017/12/31 (New southbound policy).
  • Establishment of Philippine Tropical Facility Base and Cooperative Development Program for Health Crop Products, 2018.107農科-17.1.3-糧-Z1, 2018/01/01 ~ 2018/12/31 (New southbound policy).
  1. Small Business Innovation Research (SBIR) program & Conventional industry technology development (CiTD), Ministry of Economic Affairs, Taiwan (PI: Prof. Yang-Chang Wu and Fang-Rong Chang):
  • The alliance project of application and development on highly value-added natural plant extract of Houttuynia cordata and its intelligent agriculture. We-Win bio-medical Co., Ltd., 2021/07/01 ~ 2022/06/30.
  • Development of roselle seed oil for anti-allergic skin relief and skin care raw materials and products. We-Win bio-medical Co., Ltd., 2020/09/01 ~ 2021/07/31.
  • Development project of agarwood seed oil for anti-allergic and anti-photoaging raw materials and products. We-Win bio-medical Co., Ltd., 2017/07/12 ~ 2018/07/11.
  • The product development project of Taiwanese native green processed extract-supercritical Toona sinensis extract in anti-metabolic syndrome. We-Win bio-medical Co., Ltd., 2012/10/01 ~ 2013/06/30.
  • The product development project of skin care and hypoglycemic products from Formosan thistle. Guang-Ding Biotech Co., Ltd., 2012/07/01 ~ 2012/12/31。
  1. Metal Industries Research & Development Centre (MIRDC), Ministry of Economic Affairs, Taiwan (PI: Prof. Yang-Chang Wu and Fang-Rong Chang):
  • Efficacy evaluation and mechanism investigation of Cinnamomoum osmophloeum and Toon sinensis extracts in improving metabolic syndrome, 2010/06/15 ~ 2010/11/30.
  • Efficacy evaluation and mechanism investigation of Cinnamomum osmophloeum and Toona sinensis extracts in improving insulin resistance, 2008/09/22 ~ 2009/04/30.
  1. Committee on Chinese Medicine and Pharmacy, Department of Health, Executive Yuan, Taiwan (PI: Prof. Yang-Chang Wu and Fang-Rong Chang):
  • The process of the development of Chinese medicine – evaluation for the sources of the toxicity induced by the long-term or over – Doses administration of Chinese medicinal wines, CCMP95-CP-010, 1996.
  • Promoting the safety research and education of Chinese medicine preparations – Investigation of the safety for the long-term administration of Chinese herbal alcohols, CCMP94-CP-013, 1995.
  1. Academia-Industry co-operations (PI: Prof. Yang-Chang Wu and Fang-Rong Chang):
  • Principal Investigator: Great Tree Elite Master's Program: Talent Cultivation and Recruitment Excellence Initiative – Industry-Academia Collaboration Implementation and Promotion. Grant Amount: 1,746,906/3,493,811 NTD Great Tree Pharmacy Co., Ltd., 2025/10/01-2026/09/30.
  • Principal Investigator: Great Tree Elite Master's Program: Talent Cultivation and Recruitment Excellence Initiative – Industry-Academia Collaboration Implementation and Promotion. Grant Amount: 3,493,811 NTD Great Tree Pharmacy Co., Ltd.
  • Principal Investigator: The Role of FGF17 in Prostate Adenocarcinoma: Investigating its Functions in Cell Proliferation, Migration, and Invasion through Cell Lines. Grant Amount: 300,000 NTD, Pingtung Christian Hospital, 2025/02/01-2025/12/31.
  • Principal Investigator: Second Campus Creative Proposal Competition of Great Tree Pharmacy. Grant Amount: 501,118 NTD, Great Tree Pharmacy Co., Ltd., 2024/09/15-2025/06/15.
  • Principal Investigator: Development of a Drug Carrier-Hydrogel System for the Treatment of Tenosynovitis. Grant Amount: 1,111,111 NTD, Tajen University/Min-Sheng Healthcare System, 2023/12/01-2024/11/30.
  • R&D on the bioactivities of Taiwan endemic Aiyu extract, We-Win bio-medical Co., Ltd., 2022/06/15 ~ 2022/12/31.
  • Research on a mullet material, Sea queenlet Co., Ltd., 2022/01/01 ~ 2022/12/31.
  • Composition analyses of chemical markers in Houttuynia cordata, We-Win bio-medical Co., Ltd., 2021/11/01 ~ 2022/04/30.
  • Isolation and identification of components from a natural plant, Jojia bio-tech co., Ltd., 2020/05/01 ~ 2021/12/31.
  • R&D on a cosmetic mask, Nan Liu enterprise Co., Ltd., 2020/12/15 ~ 2021/12/15.
  • Bio-active ingredients and optimal processes of roselle seed extracts, We-Win bio-medical Co., Ltd., 2020/11/01 ~ 2021/07/31.
  • Antioxidant and antitumor active compositions from Juncus effusus, Chi mei medical center, 2014/05/01 ~ 2015/04/30.
  • The product development project of Taiwanese native green processed extract – Product development of supercritical Toona sinensis extract for anti-metabolic syndrome. We-Win bio-medical Co., Ltd., 2012.
  • Bioactivity evaluations of ginger extracts, Biotanico Inc., 2008/12/01 ~ 2010/05/31.
  • Research project on chemical and biological activity profiles of Taiwan cultivated Salvia miltiorrhiza, YUF biotechnology Co. Ltd., 2009.
  • Bioactivity Screening of Citrus maxima and Plectranthus amboinicus, Sinphar pharmaceutical co. ltd., 2008.

smileyList of poster presentations in recent five years

  1. New Tech × New Era: The Ongoing Transformation of Healthcare and Telepharmacy, Nov 30th - Dec 1st, 2025, Tajen university, Taiwan. “FGF17 Promotes Proliferation, Migration, and EMT Signatures in Prostate Adenocarcinoma: Evidence from AI-Assisted Precision Oncology.” Chia-Shen Chien, Po-Chieh Wang, Ssu-Hsuan Hsu, Yi-Hong Tsai*.
  2. The 7th Taiwan Joint Conference of Pharmacy and Pharmaceutical Sciences, Nov 23rd, 2025, Taipei, Taiwan. “Molecular Mechanisms of Mitochondrial Apoptosis Induced by Coptis chinensis in U87 Glioblastoma Cells.” Yi-Hong Tsai*, Rui-Teng Lu*, I-Chi Hsu, Chih-Wun Fun, Jen-Chih Chang, Chi-Ying Li, Yu-Ming Hsu, Tzu-An Yen, Nien-Ya Wang, Wei-Hsun Lin.
  3. 2025 Taipei International Military Medicine Forum (TIMMF 2025), Nov 22nd-23rd, 2025, Taipei, Taiwan. “Dose-Dependent Pro-Apoptotic and Cytotoxic Effects of Coptis chinensis Extract on U87 Glioblastoma Cells.” I-Chi Hsu, Rui-Teng Lu, Yu-Ming Hsu, Chi-Ying Li, Pei-Jung Lai, Yi-Hong Tsai*.
  4. Joint Academic Symposium of the 40th SNP, 25th SFRR-Taiwan, 2025 TATCM, and 1st SCPS-Taiwan & Symposium on Pharmacy and Traditional Chinese Medicine, Taichung, Taiwan, Oct 24th- 26th, 2025. “Preliminary Evidence of Ferroptosis-Associated Cytotoxicity by Specifically Processed Wasabi By-Products in PA-1 Ovarian Teratocarcinoma Cells.” Chih-Yu Lee, Chiung-Hui Liu, Hsin-Yi Tsai, Wei-Ting Hou, Yi-Hong Tsai*.
  5. 2025 KMU International Conference on BioMedicine, Kaohsung, Taiwan, Oct 10th-12th, 2025. “FGF17: A Prognostic Biomarker and Therapeutic Target in Precision Medicine for Prostate Adenocarcinoma.” Po-Chieh Wang, Chia-Shen Chien, Chih-Chang Hung, Ssu-Hsuan Hsu, Yi-Hong Tsai*.
  6. The 124th Annual Meeting of the Japanese Dermatological Association, Yokohama, Japan, May 28th-Jun 1st, 2025. " Coix Agricultural By-Products as a Sustainable Source for Skin and Inflammation Therapeutics.” Yi-Hong Tsai*, Chiung-Hui Liu, Yi-Ching Lo, Tsong-Long Hwang, I-Min Liu, Pochuen Shieh, Yu-Min Ko, Zhi-Yu Li, Tzu-An Yen, Ching-Inn Wang, Jo-Chi Chen.
  7. The 145th Annual Meeting of the Pharmaceutical Society of Japan, Fukuoka, Japan, March 26-29, 2025. “28-Day Repeated-Dose Oral Toxicity Assessment of an Extract in Rats.”  Yi-Hong Tsai*, Yu-Min Ko, Chin-Chung Wu, Hui-Chun Wang, Ming-Lun Yeh, En-Liang Chu, Szu-Yin Yu, Chiung-Hui Liu, Hao-Chun Hu, I-Min Liu, Chia-Jou Fang, Yi-Ting Chen, Yu-Hsin Wu, Zhi-Yu Li, Tung-Yin Wu, Jia-Dong Yang*, Ming-Lung Yu*, Fang-Rong Chang*.
  8. The 54th Annual Meeting and Symposium of the Taiwan Association for Food Science and Technology, 2024. Taiwan Association for Food Science and Technology, New Taipei, Taiwan, November 29- December 1st, 2024. “Study on the Enhancement of Probiotic Flavor Sensory Evaluation Using Fruit Juice Powder and Acidulants.” Tai-Rui Tseng, Jin-Xiang Wu, Yue-Bin Li, Yue-Huan Li, Jing-Peng Chiu, Ying-Qi Du, You-Jie Lai, Wen-Kai Zhang, Hsueh-Wei Fu, Ding Kuei Liao, Yi-Hong Tsai*.
  9. Joint Symposium of the 39th SNP and 24th SFRR-Taiwan, 2024 -Cutting Edge, Translation and Application. The Society of Chinese Natural Medicine/The Society for Free Radical Research-Taiwan (SFRR-Taiwan), Taoyuan, Taiwan, October 04-06, 2024. “Natural resource transformation and innovation: The development of skin health conditioning and treatment agents from Coix agricultural by-products.” Yi-Hong Tsai*, Chiung-Hui Liu, Fang-Rong Chang, Yi-Ching Lo, Hsueh-Wei Chang, Hao-Chun Hu, Szu-Yin Yu, Ching-Peng Chiu, I-Min Liu, Yu-Min Ko, Pin-Jia Huang, Yu-Chiao Wang, Chia-Yu Hung, Yong-Zhen Xiao, Tzu-An Yen, Tzu-En Lin.
  10. The 38th Symposium on Natural Products—Insights into Natural Products from History & Symposium on Pharmacy and Traditional Chinese Medicine Presentation, 2023. The Society of Chinese Natural Medicine, Kaohsiung, Taiwan, October 27-239, 2023. “Advanced chemical and biological investigation of natural products from Andraca theae droppings.” Su-Chin Lin, Su-Li Chen, Mei-Chu Yang, Chein-Chen Su, Tsong-Long Hwang, Shih-Wei Wang, Yi-Hong Tsai*, Fang-Rong Chang*.
  11. The 38th Symposium on Natural Products—Insights into Natural Products from History & Symposium on Pharmacy and Traditional Chinese Medicine Presentation, 2023. The Society of Chinese Natural Medicine, Kaohsiung, Taiwan, October 27-239, 2023. “Quality and production enhancement of fish mint, Houttuynia cordata Thunb., cultivated in a hydroponic planting system with designed plant growth-promoting additives.” Yi-Hong Tsai, Yen-Chi Loo, Pin-Chia Hwang, Chen-Hsieh, Hui-Pin Hsieh, Yen-Chang Chen, Shieh-Er Chen, I-Min Liu, Chia-Chin Liao, Fang-Rong Chang*.
  12. The 37th Symposium on Natural Products & Symposium on Traditional Chinese Medicine and Pharmacy, 2022. The Society of Chinese Natural Medicine, Kaohsiung, Taiwan, October 21-23, 2022. “Composition decipherment of Ficus pumila var. awkeotsang and its potential on COVID-19 symptom amelioration and in silico prediction of SARS-CoV-2 interference.” Hao-Chun Hu, Szu-Yin Yu, Xiao-Shan Hung, Chun-Han Su, Yu-Liang Yang, Chien- Kei Wei, Yuan-Bin Cheng, Yang-Chang Wu, Chia-Hung Yen, Tsong-Long Hwang, Shu-Li Chen, István Szatmári, Attila Hunyadi, Yi-Hong Tsai**, Fang-Rong Chang*.
  13. The 37th Symposium on Natural Products & Symposium on Traditional Chinese Medicine and Pharmacy, 2022. The Society of Chinese Natural Medicine, Kaohsiung, Taiwan, October 21-23, 2022. “Analysis on Chemical Constituents of Taiwanese Reynoutria multiflora (Thunb.) Moldenke.” Yueh Yang, Cai-Qing Yin, Szu-Yin Yu, Hao-Chun Hu, Yi-Hong Tsai, Tsong-Long Hwang, Chia-Ching Liaw, Shu-Li Chen, Fang-Rong Chang*.
  14. The 37th Symposium on Natural Products & Symposium on Traditional Chinese Medicine and Pharmacy, 2022. The Society of Chinese Natural Medicine, Kaohsiung, Taiwan, October 21-23, 2022. “Estrogenic and anti-neutrophilic inflammatory phenanthrenes from Juncus effusus L.” Hao-Chun Hu1, Yi-Hong Tsai1, Kuang-Huang Wu, Yu-Che Chuang, Szu-Yin Yu, Yu-Ting Kuo, Tsong-Long Hwang, Ferenc Fülöp, Yang-Chang Wu, Fang-Rong Chang*.
  15. The 37th Symposium on Natural Products & Symposium on Traditional Chinese Medicine and Pharmacy, 2022. The Society of Chinese Natural Medicine, Kaohsiung, Taiwan, October 21-23, 2022. “Development on potential skin anti-aging agents of Cosmos caudatus Kunth via inhibition of collagenase, MMP-1 and MMP-3 activities.” Yen Chi Loo, Hao-Chun Hu, Szu-Yin Yu, Yi-Hong Tsai, Michal Korinek, Yang- Chang Wu, Fang-Rong Chang*, Ying-Jung Chen*.
  16. The 37th Symposium on Natural Products & Symposium on Traditional Chinese Medicine and Pharmacy, 2022. The Society of Chinese Natural Medicine, Kaohsiung, Taiwan, October 21-23, 2022. “Decoding Multiple Biofunctions of Maca on Its Anti-allergic, Anti- inflammatory, Anti-thrombotic, and Pro-angiogenic Activities.” Kartiko Arif Purnomo, Michal Korinek, Yi-Hong Tsai, Hao-Chun Hu, Yi-Hsuan Wang, Anders Backlund, Tsong-Long Hwang, Bing-Hung Chen, Shih-Wei Wang, Chin- Chung Wu, Fang-Rong Chang*.
  17. The 37th Symposium on Natural Products & Symposium on Traditional Chinese Medicine and Pharmacy, 2022. The Society of Chinese Natural Medicine, Kaohsiung, Taiwan, October 21-23, 2022. “The Enhancing Effects of Water Extract of Guilu Erxian Jiao on Skeletal Muscle Mass and Function in C57BL/6J mice.” Wan-Hsuan Chang, Wei-Yu Fang, Yi-Hong Tsai, Fang-Rong Chang, Yi-Ching Lo*.
  18. The 36th Symposium on Natural Products & Symposium on Traditional Chinese Medicine and Pharmacy, 2021. The Society of Chinese Natural Medicine, Kaohsiung, Taiwan, October 15-16, 2021. “Anti-allergic macapyrrolidones and macapyrrolins from maca explored through ChemGPS-NP.” Kartiko Arif Purnomo, Michal Korinek, Yi-Hong Tsai, Hao-Chun Hu, Anders Backlund, Bing-Hung Chen, Fang-Rong Chang.
  19. The 35th Symposium of Natural Product and the 3rd Dr. Tsung Ming Tu medical forum, 2020. The Society of Chinese Natural Medicine, Taipei, Taiwan, September 11-13, 2020. “Bioactive components from Epicoccum sorhinum.” Ching-Chia Chang, Chi-Ying Li, Chien-Kei Wei, Yi-Hong Tsai, Yang-Chang Wu, Tsong-Long Hwang, Chin-Chung Wu, Shih-Wei Wang, Fang-Rong Chang.
  20. The 34th Symposium of Natural Products 2019., The Society of Chinese Natural Medicine, Taoyuan, Taiwan, October 17-19, 2019. “Chemical constituents and bioactivities from the roots of Physalis peruviana.” Yu-Chi Lin, Bo-Yi Yao, Yi-Hong Tsai, Hao-Chun Hu, Tsong-Long Hwang, Fang-Rong Chang, Yuan-Bin Cheng.
  21. The 34th Symposium of Natural Products 2019., The Society of Chinese Natural Medicine, Taoyuan, Taiwan, October 17-19, 2019. “Acylated flavonoid glycosides from the twigs and leaves of Gleditsia rolfei and Their Anti-influenza Activity.” Zie-Che Yang, Yi-Hong Tsai, Chia-Hung Yen, Fang-Rong Chang.
  22. The 34th Symposium of Natural Products 2019., The Society of Chinese Natural Medicine, Taoyuan, Taiwan, October 17-19, 2019. “Research on the chemical constituents and bioactivities of Epicoccum sorghinum isolated from Arundo donax L.” Ching-Chia Chang, Chi-Ying Li, Chien-Kei Wei, Yi-Hong Tsai, Yang-Chang Wu, Tsong-Long Hwang, Chin-Chung Wu, Shih-Wei Wang, Fang-Rong Chang.
  23. PSE-Young Scientists' Meeting 2019., Phytochemical Society of Europe, Budapest, June 19-22, 2019. “Development of traditional complex formulas as therapeutic agents.” Yi-Hong Tsai, Yu-Ting Tseng, Tung-Yin Wu and Yi-Ching Lo*, Fang-Rong Chang*.
  24. American Society of Pharmacognosy 2019 Annual Meeting, Madison, Wisconsin, July 13-17, 2019. “Chemical and biological investigation of natural products from Epicoccum sorghinum.” Fang-Rong Chang*, Ching-Chia Chang, Chi-Ying Li, Yi-Hong Tsai, and Chien-Kei Wei.
  25. The 17th Meeting of Consortium for Globalization of Chinese Medicine (CGCM), Kuching-Sarawak, Malaysia, August 8-10, 2018. “Deciphers on the Chemical Constituents and Biological Activities of the Fruiting Body of Cordyceps militaris.” Ching-Peng Chiu, Yi-Hong Tsai, Fang-Rong Chang.